Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05300529
Other study ID # UjaFM
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 1, 2021
Est. completion date April 1, 2022

Study information

Verified date October 2022
Source University of Jaén
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to analyze the effectiveness of Vestibular Rehabilitation for improving balance and quality of life of patients with Fibromyalgia Syndrome (SFM). Recruited subjects will be randomly assigned to an experimental group or control group (placebo). The experimental group will receive a standard Vestibular Rehabilitation program focused on eye stabilization and Vestibulo-Ocular Reflex (VOR) gain with the aim of improving motor and sensory strategies, while the control group will carry out a conventional rehabilitation program that will not include sensory strategy training. The frequency of treatment for both groups will be twice/week, along with daily performing (2 times/day, 5 days/week) of exercises at home. The total duration will be 8 weeks. The outcome measure are: disease impact (FIQ), perceived vertigo (DHI), and confidence in balance (ABC), at pre-treatment, post-treatment, one month follow-up and three months follow-up.


Description:

Fibromyalgia Syndrome (SFM) affects approximately 0.5 - 5% of the global population with ambiguity in diagnosis, physiopathology uncertainty and complex treatment. Recent studies have shown frequent episodes of postural instability in SFM patients. This balance affectation seems to correlate with disturbances of quality of life, pain, impact of the disease, daily life activities and increased risk of falls. However, there is still controversy over the exact mechanism that explains this nonspecific balance disorder. Despite this preliminary finding of a possible visual and vestibular disorder, there are not known studies justifying the alteration of vestibular functions present in Fibromyalgia. Also, the are not certainty that Vestibular Rehabilitation (VR) provides short- and medium-term benefits. Derived from the deficiencies observed in the revised literature, we propose to analyze the effectiveness of a Vestibular Rehabilitation program improving the balance and quality of life of people with Fibromyalgia Syndrome (SFM). Therefore, a randomized, simple blind, two-group parallel controlled clinical trial has been designed to assess the effectiveness of Vestibular Rehabilitation treatment focused on eye stabilization exercises. Subjects will be recruited from the JaƩn Fibromyalgia Association (AFIXA) and randomly assigned to an experimental group or control group (placebo). Subjects who are diagnosed with SFM and between 18 and 70 years of age will be selected. The experimental group will receive a standard Vestibular Rehabilitation program focused on the stabilization of the eye and gain of the Vestibulo-Oculo Reflex (VOR), while in the control group a conventional rehabilitation program will be carried out without visual stimulation. The frequency of treatment for both groups will be twice/week, along with daily exercises at home (2 times/day). The total duration will be 8 weeks. Measurements will be made in pretreatment, aftertreatment and one month follow-up and three months follow-up.


Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date April 1, 2022
Est. primary completion date December 20, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Aged 18-70 years, - Diagnostic for fibromyalgia as described by the 2016 American College of Rheumatology (ACR) Exclusion Criteria: - Cognitive impairment impacting ability to fill out the scales and questionnaires. - Musculoskeletal surgical intervention in the preceding 6 months and/or acute traumatic pathology to the inferior limb(s). - Musculoskeletal disease with deformity of the inferior limbs. - Diagnosed with vestibular, visual and/or auditory pathology. - Neurologic illness that could be the cause of a balance disorder.

Study Design


Intervention

Other:
Vestibular Rehabilitation Exercises
The Vestibular Rehabilitation program focuses on stabilizing the gaze and gaining the Vestibular Ocular Reflex (VOR). The general mechanisms of recovery from vestibular injuries are vestibular adaptation and replacement exercises, which are designed to improve gaze stability and the interaction between sight and the vestibular system during head movements. The exercises will be carried out progressively according to the tolerance of the patient, varying the stimulus in intensity and frequency.
Conventional Rehabilitation exercises
The conventional rehabilitation program in which exercises are performed to improve joint range, flexibility, and gait. It will always be done with the eyes open, on a firm surface and will not include training in sensory strategies

Locations

Country Name City State
Spain University os Jaén Jaén

Sponsors (1)

Lead Sponsor Collaborator
University of Jaén

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Other Height (Anthropometrics Data) Patient height measured in meters (m) Baseline
Other Weight (Anthropometrics Data) Patient's body weight in kilograms (kg) Baseline
Other Body Mass Index (Anthropometrics Data) Weight and height will be combined to report body mass index in kg/m^2 Baseline
Other Demographics Data Registration of information provided by the patient on sex, age, education level. occupation and civil status Baseline
Primary FIQ (Fibromyalgia Impact Questionnaire) Evaluates the impact of fibromyalgia on the patient's quality of life.The total score of the FIQ is from 0 to 100. A higher score means a greater impact of the disease on the patient. Baseline
Primary FIQ (Fibromyalgia Impact Questionnaire) Evaluates the impact of fibromyalgia on the patient's quality of life.The total score of the FIQ is from 0 to 100. A higher score means a greater impact of the disease on the patient. at eight weeks
Primary FIQ (Fibromyalgia Impact Questionnaire) Evaluates the impact of fibromyalgia on the patient's quality of life.The total score of the FIQ is from 0 to 100. A higher score means a greater impact of the disease on the patient. at twelve weeks
Primary ABC-16 (Activities-specific Balance Confidence scale-16 items) Evaluates the balance confidence in performing activities of daily living. The total score of the ABC-16 is from 0% to 100%, with higher values associated with higher balance confidence. Baseline
Primary ABC-16 (Activities-specific Balance Confidence scale-16 items) Evaluates the balance confidence in performing activities of daily living. The total score of the ABC-16 is from 0% to 100%, with higher values associated with higher balance confidence. at eight weeks
Primary ABC-16 (Activities-specific Balance Confidence scale-16 items) Evaluates the balance confidence in performing activities of daily living. The total score of the ABC-16 is from 0% to 100%, with higher values associated with higher balance confidence. at twelve weeks
Primary DHI (Dizziness Handicap Inventory) Evaluates the level of disability related to the impact of dizziness on daily function and quality of life. The total score of the DHI is from 0 to100 points. A higher score indicates a greater degree of disability due to the vertiginous symptoms. Baseline
Primary DHI (Dizziness Handicap Inventory) Evaluates the level of disability related to the impact of dizziness on daily function and quality of life. The total score of the DHI is from 0 to100 points. A higher score indicates a greater degree of disability due to the vertiginous symptoms. at eight weeks
Primary DHI (Dizziness Handicap Inventory) Evaluates the level of disability related to the impact of dizziness on daily function and quality of life. The total score of the DHI is from 0 to100 points. A higher score indicates a greater degree of disability due to the vertiginous symptoms. at twelve weeks.
Secondary CSI (Central Sensitization Inventory) Evaluates a wide range of somatic and emotional symptoms common to central sensitization syndromes (CSS). The total score of the CSI from 0 to 100. Higher scores indicate greater severity of symptoms. Baseline
Secondary CSI (Central Sensitization Inventory) Evaluates a wide range of somatic and emotional symptoms common to central sensitization syndromes (CSS). The total score of the CSI from 0 to 100. Higher scores indicate greater severity of symptoms. at eight weeks
Secondary CSI (Central Sensitization Inventory) Evaluates a wide range of somatic and emotional symptoms common to central sensitization syndromes (CSS). The total score of the CSI from 0 to 100. Higher scores indicate greater severity of symptoms. at twelve weeks.
Secondary PCS (Pain Catastrophizing Scale) Evaluates the patient's catastrophic thoughts. The total score of the PCS from 0 to 52. Higher scores indicate a greater presence of catastrophic thoughts. Baseline
Secondary PCS (Pain Catastrophizing Scale) Evaluates the patient's catastrophic thoughts. The total score of the PCS from 0 to 52. Higher scores indicate a greater presence of catastrophic thoughts. at eight weeks
Secondary PCS (Pain Catastrophizing Scale) Evaluates the patient's catastrophic thoughts. The total score of the PCS from 0 to 52. Higher scores indicate a greater presence of catastrophic thoughts. at twelve weeks.
Secondary TSK (Tampa Scale for Kinesiophobia) Evaluates fear of movement to injury. The total score of the TSK from 11 to 44 points. Higher scores indicate a greater fear of movement. Baseline
Secondary TSK (Tampa Scale for Kinesiophobia) Evaluates fear of movement to injury. The total score of the TSK from 11 to 44 points. Higher scores indicate a greater fear of movement. at eight weeks
Secondary TSK (Tampa Scale for Kinesiophobia) Evaluates fear of movement to injury. The total score of the TSK from 11 to 44 points. Higher scores indicate a greater fear of movement. at twelve weeks.
Secondary VAS-pain (Visual Analogue Scale) Evaluates the pain on a numerical scale from 0 to 10. Higher scores indicate more pain Baseline
Secondary VAS-pain (Visual Analogue Scale) Evaluates the pain on a numerical scale from 0 to 10. Higher scores indicate more pain at eight weeks
Secondary VAS-pain (Visual Analogue Scale) Evaluates the pain on a numerical scale from 0 to 10. Higher scores indicate more pain at twelve weeks
Secondary SF-12 (12-Item Short Form Survey) Evaluates the impact of health on an individual's everyday life. Used as a quality of life measure. Baseline
Secondary SF-12 (12-Item Short Form Survey) Evaluates the impact of health on an individual's everyday life. Used as a quality of life measure. at eight weeks
Secondary SF-12 (12-Item Short Form Survey) Evaluates the impact of health on an individual's everyday life. Used as a quality of life measure. at twelve weeks
Secondary FES-I (Falls Efficacy Scale-International) Evaluates the fear of falling. The total score of the FES-I from 16 to 64 points. Higher scores indicate greater fear of falling. Baseline
Secondary FES-I (Falls Efficacy Scale-International) Evaluates the fear of falling. The total score of the FES-I from 16 to 64 points. Higher scores indicate greater fear of falling. at eight weeks
Secondary FES-I (Falls Efficacy Scale-International) Evaluates the fear of falling. The total score of the FES-I from 16 to 64 points. Higher scores indicate greater fear of falling. at twelve weeks
Secondary FSS (Fatigue Severity Scale) Evaluates severity of fatigue. Higher scores indicate a greater severity of fatigue Baseline
Secondary FSS (Fatigue Severity Scale) Evaluates severity of fatigue. Higher scores indicate a greater severity of fatigue at eight weeks
Secondary FSS (Fatigue Severity Scale) Evaluates severity of fatigue. Higher scores indicate a greater severity of fatigue at twelve weeks
Secondary 20-item JAEN screening tool Evaluates balance and neuromotor function in patients with fibromyalgia. Thd total scale of the Jaen-Screening Tools, from 0 to 80 points. A higher score indicates a greater degree of balance disorder. Baseline
Secondary 20-item JAEN screening tool Evaluates balance and neuromotor function in patients with fibromyalgia. Thd total scale of the Jaen-Screening Tools, from 0 to 80 points. A higher score indicates a greater degree of balance disorder. at eight weeks
Secondary 20-item JAEN screening tool Evaluates balance and neuromotor function in patients with fibromyalgia. Thd total scale of the Jaen-Screening Tools, from 0 to 80 points. A higher score indicates a greater degree of balance disorder. at twelve weeks
Secondary SVV (Subjective Visual Vertical) Evaluates the perception of verticality, measured using the Subjective Visual Vertical (SVV) test using a virtual reality device. baseline
Secondary SVV (Subjective Visual Vertical) Evaluates the perception of verticality, measured using the Subjective Visual Vertical (SVV) test using a virtual reality device. at eight weeks
Secondary SVV (Subjective Visual Vertical) Evaluates the perception of verticality, measured using the Subjective Visual Vertical (SVV) test using a virtual reality device. at twelve weeks
Secondary Stabilometric Platform Instrument composed of resistive pressure sensors, used to measure the static or postural balance. The test was performed under both eyes-open and eyes-closed conditions. Baseline
Secondary Stabilometric Platform Instrument composed of resistive pressure sensors, used to measure the static or postural balance. The test was performed under both eyes-open and eyes-closed conditions. at eight weeks
Secondary Stabilometric Platform Instrument composed of resistive pressure sensors, used to measure the static or postural balance. The test was performed under both eyes-open and eyes-closed conditions. at twelve weeks
Secondary Therapeutic Adherence at home It assesses adherence to home treatment through a weekly record diary, where patients must record the number of times a day they perform the prescribed exercises, with a range of 0 to 80. Higher scores indicate greater adherence to home treatment. A score of 80 indicates 100% adherence. Throughout the intervention phase, eight weeks
Secondary Satisfaction level Evaluates the level of satisfaction using a Likert scale, with five response options, from "very dissatisfied" to "very satisfied". The total score of 0-24. A high score indicates greater satisfaction at eight weeks
Secondary GRC (Global Change Rating Scales) Assesses whether the patient's health status has improved or deteriorated after the treatment received, with ten response options ranging from "the worst it could be" to "the best it could be" at eight weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05659862 - Digitally Assisted Behavioral Physical Activity Intervention in Fibromyalgia N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT03042728 - Impact of Inclusion of a Therapy Dog Visit as Part of the Fibromyalgia Treatment Program N/A
Recruiting NCT06097091 - Effects and Mechanisms of Pain Neuroscience Education in Patients With Fibromyalgia N/A
Recruiting NCT04554784 - Effectiveness of Bowen Therapy for Pain Management in Patients With Fibromyalgia N/A
Completed NCT03300635 - Metabolism, Muscle Function and Psychological Factors in Fibromyalgia N/A
Recruiting NCT06166563 - Exercise, Irritable Bowel Syndrome and Fibromyalgia N/A
Completed NCT03227952 - Sensory Stimulation in Fibromyalgia N/A
Completed NCT03166995 - Postural Exercises in Women With Fibromyalgia N/A
Recruiting NCT06237595 - Vagus Nerve Stimulation in Fibromyalgia N/A
Completed NCT01888640 - Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST) N/A
Completed NCT03641495 - Pain Education and Therapeutic Exercise for Fibromyalgia N/A
Recruiting NCT05581628 - FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE
Active, not recruiting NCT05128162 - Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia Phase 2
Completed NCT04674878 - Comparison of Muscle Energy Techniques and Breathing Exercises for Functional Improvement in Fibromyalgia N/A
Active, not recruiting NCT04084795 - Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia N/A
Completed NCT03129906 - Impact of the Restriction of Sources of Gluten in Fibromyalgia Patients N/A
Completed NCT05058911 - Exposure-based Cognitive Behavior Therapy vs Traditional Cognitive Behavior Therapy for Fibromyalgia N/A
Recruiting NCT04571853 - New Educational Tool for FM N/A
Recruiting NCT04571528 - Effectiveness of VIRTUAL FIBROWALK STUDY N/A